Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the Covid-19 Era

AuthID
 P-00V-XM6
13
Author(s)
Schreiber, S
·
Alten, R
·
Westhovens, R
·
Peyrin Biroulet, L
·
Danese, S
·
Takeuchi, K
·
Magro, F
·
An, Y
·
Kim, DH
·
Yoon, S
·
Document Type
Review
Year published
2022
Published
in ADVANCES IN THERAPY, ISSN: 0741-238X
Volume: 39, Issue: 6, Pages: 2342-2364 (23)
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 34988877
SCOPUS: 2-s2.0-85122363368
Wos: WOS:000739243600001
Source Identifiers
ISSN: 0741-238X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service